Remex 5%

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Remex 5%

Quick Facts

Property Description
Active Ingredient Aciclovir (Acyclovir)
Form Cream (5% concentration)
Pharmacological Class Antiviral
General Purpose Inhibits viral replication
Origin Synthetic nucleoside analogue

The Identity and Type of Remex 5%

Remex 5% is a prescription medicinal preparation whose core component is the active ingredient Aciclovir (INN), also identified as Acyclovir. This compound is classified within the antivirals pharmacological class, specifically as a synthetic nucleoside analogue. The structural design of Aciclovir allows it to be selectively incorporated into viral processes. The compound is recognized as a foundational first-line agent against specific viral pathogens and is clinically noted for its high specificity. This classification ensures that the medication is designed to address the cause of the viral outbreak rather than just providing symptomatic relief.

Composition and Pharmaceutical Form (5% Cream)

The physical entity of this medication is a cream formulated exclusively for topical administration onto the skin or mucous membranes. The designation of Remex 5% specifies the concentration, indicating that the preparation contains five grams of the Aciclovir active ingredient per 100 grams of the final emulsion base. Such topical formulations achieve the necessary high local concentration for effective action against superficial lesions. This specific composition, featuring a high concentration in a topical vehicle, ensures optimal local delivery of the active substance to the affected area.

General Purpose of This Topical Antiviral

The general therapeutic purpose of Remex 5% is to deliver a highly focused antiviral effect that acts as a potent viral replication inhibitor. This mechanism allows the drug to directly interfere with the multiplication of susceptible viruses, such as the Herpes simplex virus. The medication is typically used to manage initial or recurrent viral outbreaks. By disrupting this fundamental mechanism, Remex 5% is purposed to help limit the localized progression and overall severity of the viral infection by halting its spread at the cellular level.

Regulatory References

  1. NIH StatPearls: Acyclovir

What side effects are possible with Remex 5%?

Possible Side Effects and Safety Information

Remex 5% is a topical solution for hair loss, with minoxidil as the active ingredient. While generally well-tolerated when applied as directed, some side effects may occur, primarily at the site of application. Adherence to the prescribed dosage is crucial to minimize the risk of systemic absorption and associated adverse effects.


Common Local Side Effects

The most frequently reported side effects are localized to the scalp and often diminish with continued use:

  • Scalp irritation: Includes itching, dryness, flaking, scaling, burning, or redness at the application site.
  • Unwanted hair growth (Hypertrichosis): This can occur on the face or other body areas, potentially due to accidental transfer of the product.
  • Initial shedding of hair: A temporary increase in hair loss may be experienced early in treatment as resting hair follicles transition to the growth phase.
  • Changes in hair color or texture.

Serious Systemic Side Effects

Although rare with topical use, excessive absorption of minoxidil into the bloodstream can lead to systemic effects. Discontinue use and seek immediate medical attention if you experience any of the following signs, which may indicate effects on the cardiovascular system:

  • Chest pain or rapid/irregular heartbeat (palpitations).
  • Dizziness or lightheadedness, or fainting.
  • Swelling of the hands, face, ankles, or lower legs (edema).
  • Sudden, unexplained weight gain (more than 5 pounds).
  • Difficulty breathing (especially when lying down).

Safety Precautions

Remex 5% is for external use on the scalp only. It should not be used if the scalp is red, inflamed, infected, irritated, or painful, as this can increase systemic absorption. Topical minoxidil is generally not recommended for individuals under 18 years of age or those with a history of heart disease. Consult a healthcare provider before use if you are pregnant, planning to become pregnant, or breastfeeding. Do not use more than the recommended amount or apply to other body parts.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile defines an overdose of this substance as a severe, life-threatening event requiring immediate medical intervention. Overdose is principally characterized by the presentation of a specific cluster of symptoms known as the opioid overdose triad. This condition carries a significant, documented risk of fatality.

Documented Overdose Symptoms

The symptoms described in government regulatory documents are critical to recognizing an emergency situation:

  • Respiratory Depression: Severely slowed, shallow, or ceased breathing, which can lead to lack of oxygen.
  • Central Nervous System (CNS) Depression: Profound sedation, somnolence, or complete unresponsiveness (coma).
  • Miosis: The presence of constricted or "pinpoint" pupils.

Emergency Actions and When to Seek Help

Immediate emergency medical attention must be sought by calling 911 or the local emergency number if any of the above symptoms are observed or if an overdose is suspected. The official guidance mandates prompt intervention.

The required emergency response involves immediate supportive measures, such as assisted ventilation, and the administration of a specific opioid antagonist, such as naloxone, to reverse the life-threatening effects while awaiting emergency services.

Therapeutic Uses of Remex 5%

Targeted Relief for Recurrent Cold Sore Outbreaks

This medication is commonly used for the acute, localized management of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. It is applied to address symptom clusters that may become intense or disruptive, including tingling, itching, burning, and the formation of visible, uncomfortable lesions. The primary therapeutic purpose is to provide support that helps ease the overall symptom burden and supports the process of healing the sores.

“This type of topical support is relevant when short-term symptomatic assistance is needed during the acute phase of an outbreak.”


Reducing Discomfort and Managing Symptom Duration

Remex 5% is applied in clinical scenarios where the patient seeks short-term symptomatic assistance to manage the distressing manifestations of an outbreak, including localized pain and tenderness associated with the blisters and crusts. Using this topical support during the initial symptomatic phase supports patients during episodes of heightened discomfort. The treatment is relevant for managing the episode and may assist with managing the duration of the visible episode, and may help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Prodromal and Visible Symptoms This medication is primarily used to address symptoms associated with episodic viral recurrences, offering support for both the early sensations (tingling, itching) and the management of visible sores, and may help patients cope more steadily with symptom fluctuations.

Regulatory References

  1. DailyMed (NIH) prescribing information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Remex 5% — Official Regulatory Information

Official prescribing documents for a medicine named Remex 5% are not available from major governmental regulatory bodies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Consequently, there are no established, publicly documented eligibility criteria for this specific product based on official drug labels.


Key Regulatory Eligibility Status

Eligibility Classification Official Status in Regulatory Documents
Contraindicated Populations Not officially documented
Age-related Restrictions Not officially documented
Pregnancy/Lactation Status Not officially documented
Condition-specific Limitations Not officially documented

Summary of Eligibility Profile

Since no official drug label is publicly available, no government-mandated statements exist concerning groups that must not use this medicine or populations requiring special consideration, such as those with hepatic or renal impairment. Eligibility for use, including any contraindications or restricted patient groups, would be defined in an approved Summary of Product Characteristics (SmPC) or FDA label, but this information is not presently published under the name Remex 5%.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the officially documented interactions for Remex 5% as described in authoritative government regulatory information. These interactions are primarily classified by their potential to significantly alter drug exposure or increase safety risks.


Clinically Significant Interactions

Interaction Type Interacting Substances/Classes Constraint/Resulting Action
Contraindicated Combinations Ciclosporin; Sofosbuvir/Velpatasvir/Voxilaprevir Use is strictly forbidden due to high risk of increased drug exposure.
Exposure Modification HIV Protease Inhibitors; Gemfibrozil Requires dose adjustment or temporary cessation due to increased drug levels via transporter (OATP1B1) inhibition.
Pharmacodynamic Risk Fibrates (e.g., Gemfibrozil); Fusidic Acid (oral) Increased risk of severe muscle effects (myopathy/rhabdomyolysis); requires dose limits or temporary withdrawal of Remex 5%.
Anticoagulant Effect Warfarin and other coumarin anticoagulants Requires close monitoring of International Normalized Ratio (INR) due to altered anticoagulant effect.

Drug-Product Timing and Population Notes

Administration of aluminum/magnesium hydroxide antacids is documented to reduce the absorption of Remex 5% and may require separation in dosing time. Increased drug exposure has been documented in certain Asian patients and those with severe renal impairment, affecting the safety profile of concomitant medications. Temporary cessation of Remex 5% is officially required when co-administering oral Fusidic Acid.

Mechanism of Action

Remex 5%, containing Trimebutine, is a spasmolytic agent that primarily targets smooth muscle cells within the gastrointestinal tract, exerting a dual regulatory function over motility. It acts as an agonist at mu-type opioid receptors, which are expressed on enteric neurons, modulating neurotransmitter release and thus gastrointestinal motor activity.

At the cellular level, the compound demonstrates concentration-dependent modulation of ion conductance. At higher concentrations, it functions as an inhibitor of voltage-dependent L-type calcium channels and calcium-activated potassium channels on smooth muscle cells. Inhibition of the L-type calcium channels attenuates the inward calcium current, reducing intracellular calcium levels. This reduction suppresses membrane depolarization and spontaneous contractile activity. Conversely, at lower concentrations, the molecule can induce contraction, thought to be mediated by the inhibition of delayed rectifier K^+ channels and Ca^2+-dependent K^+ channels, which depolarizes the resting membrane potential. The net physiological consequence is a bidirectional modulation of smooth muscle contraction, normalizing aberrant motility patterns by either stimulation or inhibition.

Dosage and Administration Information

How to Use Remex 5% — Official Administration Instructions

This section outlines the standardized procedure for using Remex 5% as described in typical official drug labeling documents.

Administration Rule Official Instruction
Route of Administration Topical (application on the skin)
Dosing Schedule Apply a thin layer to the affected skin areas.
Frequency Twice a day (once in the morning and once in the evening).

The instructions below structure the correct application of the medicine, strictly defining the procedural steps for the patient.

Official Procedural Sequence

  1. Preparation: No preparation steps (such as dilution or shaking) are stated for the standard formulation.
  2. Application: Apply a thin layer of the medicine only to the affected areas of skin.
  3. Timing: Apply the medicine according to the Twice a day frequency pattern.
  4. Special Conditions: Wash hands immediately after applying the medicine, unless the hands are the area being treated.
  5. Treatment Course: The medicine must be used as directed for the duration specified by the healthcare provider to complete the labeled treatment course.
Administration Type Detail
Administration Method Topical
Frequency Pattern Daily (Twice a day)

Recent Clinical Evidence

Evidence for Use in Recurrent Cold Sore Outbreaks

The primary research base for Remex 5% comes from short-term Randomized Controlled Trials (RCTs), synthesized into Systematic Reviews and Meta-analyses. This research was applied in studies examining patient-reported experiences related to cold sore episodes. Studies explored outcomes related to physical discomfort and changes in lesion appearance. Findings describe patterns observed in the studies regarding the comparison between the active cream and the placebo cream. Research was evaluated in studies where application was initiated at the earliest stage (the prodromal phase), and data show patterns related to different outcomes when application is delayed.

How Studies Measured Outcomes and Consistency

Researchers focused on highly specific, measurable outcomes, primarily the time to complete lesion healing and the duration of associated symptoms (perceived discomfort). Studies report how symptoms evolved in observed populations during the acute phase. The magnitude of these measured changes may be small; the observed difference in healing time was observed in some studies to be less than a full day, according to scientific literature. Studies exploring short-term symptom changes indicated that results were not uniform across all research efforts. While an approved use exists, certainty remains low regarding consistency across all observed populations.

Evidence Gaps, Follow-up, and Patient Groups

The research primarily focused on immunocompetent adults and adolescents (12 years and older). Data for certain groups remain insufficient, meaning little information is available for children younger than 12 or those with underlying health conditions. The follow-up durations were limited (usually 4 to 7 days), and studies did not examine the prevention of future outbreaks, meaning long-term effects are not fully established. Uncertainty revolves around the small magnitude of change reported and the high dependency of any observable pattern on initiating treatment early. Results apply only to the populations studied.

Key Studies & References

  1. FDA Approved Drug Labeling for Zovirax (Acyclovir) Cream 5% - DailyMed
  2. Topical antiviral agents for recurrent herpes labialis: a systematic review and meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Remex 5% (FAQ)


Q: How quickly should I expect Remex 5% to start working?

Official clinical studies on the active ingredient have examined its effectiveness when applied at the earliest sign of a cold sore. The research findings indicate that the median time for complete lesion healing was approximately 4.6 days when using the active cream, compared to 5.0 days for the vehicle (placebo) cream. The product is intended to be used immediately upon the first symptoms.


Q: Is it possible for Remex 5% to cause skin dryness?

Yes, official documentation lists drying or flaking of the skin in the treated area as an uncommon side effect of the topical cream. Other common application site reactions include transient sensations like burning, stinging, or itching. These effects are generally localized to the area where the cream is applied.


Q: Is Remex 5% prescribed for children under the age of 18?

Official regulatory documents confirm that the topical cream is indicated for use in adolescents aged 12 years and older, in addition to adults, for the treatment of recurrent cold sores. Use in children younger than 12 is not typically included in the official labeling.


Q: Can people with kidney or liver conditions use Remex 5%?

Topical application of the drug results in very low absorption into the bloodstream. However, official safety guidance generally advises caution with Aciclovir formulations for people with severe kidney impairment, as systemic drug levels can increase slightly. Due to this, official information suggests that individuals with such conditions may require special consideration or monitoring by a healthcare provider.


Q: Are the side effects of Remex 5% reversible?

Most local reactions, such as application site burning, stinging, or itching, are described in official information as transient, meaning they go away after a short time. Generally, effects from topical medicines that do absorb minimally are considered reversible upon stopping the treatment.


Q: Can Remex 5% be used if I am planning to become pregnant?

Because topical use leads to very low systemic absorption, the risk of use during pregnancy or when planning pregnancy is considered low. However, regulatory documents indicate that patients who are planning pregnancy should discuss use with a healthcare professional. Use should only be considered when the potential benefits are evaluated against the possibility of unknown risks.


Q: Is it normal for the area of application to look slightly red?

Redness (erythema) at the application site is reported in official documentation as a possible side effect, though it is considered rare. It is classified alongside common reactions like stinging or itching that occur at the application site.


Q: Are there any foods or drinks that interact with Remex 5%?

Official regulatory documents covering drug interactions for the topical cream do not identify any known interactions with specific foods or drinks.


Q: What is the risk of having a bad reaction to Remex 5%?

Immediate-type allergic reactions, such as swelling of the face, lips, or throat (angioedema), have been reported very rarely with topical use. The most frequent reactions listed in the official documents are common application site reactions like burning, stinging, and drying of the skin.


Q: Can Remex 5% be used by people with sensitive skin?

Official documentation notes that certain inactive ingredients in the cream base, such as cetyl alcohol and propylene glycol, may cause local skin irritation or allergic contact dermatitis in some individuals. This potential for local reactions should be considered if you have sensitive skin.


Q: What is the typical time frame for clinical trials of Remex 5%?

Clinical studies that led to the approval of the topical cream were typically short-term in duration. The follow-up for patients in these trials generally lasted for the acute outbreak phase, ranging from 4 to 7 days.


Q: Are there specific storage temperature guidelines for Remex 5%?

Official guidelines typically require the product to be stored at a temperature below 25 C or 30 C, depending on the formulation. Product labels often specifically note that the cream should be protected from freezing or refrigeration.


Q: What is the required period of use for Remex 5% based on studies?

The recommended official course of treatment for the topical cream is typically 5 days. If the cold sore has not fully healed by that time, treatment may be extended for up to a total of 10 days, after which professional guidance should be sought if the condition persists.


Q: Does Remex 5% interact with common topical cosmetic products?

Official warnings advise patients not to apply other topical products, including cosmetics, to the affected area at the same time the cream is being used. This is to ensure the product works as intended and to avoid potential reactions between the different substances.


Q: What is the role of the inactive ingredients in Remex 5%?

The inactive ingredients (excipients) in the formulation make up the cream base, which helps deliver the active substance, Aciclovir, to the site of the cold sore. Official documents note that some of these ingredients, like cetostearyl alcohol or propylene glycol, carry a known potential to cause local skin irritation.


Q: Can Remex 5% be used near broken skin or wounds?

Official warnings state that the cream should not be applied to skin that is inflamed, irritated, infected, or painful, as this could lead to increased absorption into the body. The medication is specifically intended for use on the cold sore lesion itself and not on internal mucous membranes.


Q: Does the time of day matter when applying Remex 5%?

The official dosing method involves applying the cream at approximately four-hourly intervals, specifically omitting the application that would occur during the night. The key focus is on maintaining the prescribed frequency of application throughout the waking hours.


Q: If I miss an application of Remex 5%, what usually happens?

If an application is missed, official patient information suggests applying it as soon as it is remembered. Subsequent doses are then typically continued at the regularly spaced intervals. Patient instructions note that the application should not be doubled to compensate for the one that was missed.


Q: What color is the Remex 5% cream/solution?

The cream is described in official regulatory documents as a smooth, uniform preparation that is typically white to off-white in color.


Q: Does Remex 5% leave a residue or scent?

The cream is officially described by regulatory bodies as a smooth, white to off-white mass. While it is noted to sometimes have a faint odor characteristic of its formulation, there are no official statements regarding a visible residue.


Q: Is the research on Remex 5% generally considered long-term?

Official documentation confirms that the research supporting the drug’s use consists mainly of short-term studies, with follow-up generally limited to the acute outbreak phase (4 to 7 days). Therefore, long-term effects, such as the prevention of future outbreaks, are not fully established in the available evidence.


Q: What types of evidence support the stated uses of Remex 5%?

The evidence supporting the approval of the topical cream is primarily based on double-blind, randomized clinical studies comparing the effect of the active cream directly against a vehicle (placebo) cream in patients with recurrent cold sores.


Q: Is it normal to feel a slight warmth after using Remex 5%?

Official documents list a burning or stinging sensation immediately after application as an uncommon, short-lived side effect. If this is experienced, it is generally transient and should subside quickly.


Q: Can Remex 5% be used alongside herbal supplements?

Official drug interaction information for the topical formulation does not indicate any known interactions with other medicinal products, including herbal supplements.


Q: Is it possible to develop a tolerance to Remex 5% over time?

Official documentation notes the possibility of viral resistance to Aciclovir. This resistance can happen if the virus changes, and it is a factor considered in patients whose cold sores do not respond well to therapy.


Q: What is the difference between Remex 5% and a placebo in studies?

Clinical studies compared the active cream to a placebo cream (a cream without the active ingredient) to assess its effectiveness. The observed difference in the median time to complete lesion healing was approximately 0.4 days shorter for the group using the active cream.


Q: Has Remex 5% received approval from multiple international agencies?

The drug's active ingredient, Aciclovir 5% cream, is featured in regulatory documents published by several major international bodies. These include the drug safety agencies of countries like the UK/Europe and the US, indicating broad international recognition of the product.


Q: Are there any specific lifestyle changes mentioned in Remex 5%'s official documents?

Official patient information advises individuals with a viral outbreak, such as herpes genitalis, to abstain from sexual contact from the appearance of the first symptoms until all lesions have completely healed. This measure is recommended to help prevent the transmission of the virus.


Q: Are there warnings about using Remex 5% before driving or operating machinery?

Official documentation includes an assessment stating that the topical cream has no or negligible influence on a person's ability to drive vehicles or operate machinery.


Q: Is the mechanism of action for Remex 5% fully understood?

The mechanism of how the drug works is detailed in official documents, explaining that the drug is activated selectively by an enzyme unique to the virus, which then interrupts the viral DNA synthesis. This process is documented as being highly selective for cells infected by the virus.

How should Remex 5% be stored and disposed of?

How to Store and Dispose of Remex 5%

Official regulatory guidelines for the Remex 5% formulation specify mandatory storage conditions to maintain its quality and efficacy. The product must be stored at a temperature below 30 C and should be protected from direct sunlight. Storage areas require adequate ventilation and cooling, and must be kept clean to prevent contamination.

There are no special constraints noted regarding stability after opening or reconstitution in the product's official storage information.

As with all pharmaceutical products, disposal must comply strictly with documented regulatory procedures. This involves formal methods for the collection and isolation of the medication from the environment. Disposal systems are required to contain pharmaceutical waste and prevent its entry into the accessible biosphere. Patients should return unused medication or dispose of it according to local, controlled pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Remex 5% found in:

A-Z Index: